Medications for Seizures
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Seizures.
Found 32 Approved Drugs for Seizures
Levetiracetam
Brand Names
Spritam, Keppra, Roweepra, Elepsia
Levetiracetam
Brand Names
Spritam, Keppra, Roweepra, Elepsia
Form: Injection, Tablet, Solution
Method of administration: Oral, Intravenous
FDA approval date: April 24, 2000
Primary Generalized Tonic-Clonic Seizures Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults with idiopathic generalized epilepsy. Partial Onset Seizures Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in thetreatment of partial onset seizures in adults with epilepsy. Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adult patients (16 years and older) when oral administration is temporarily not feasible. Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adjuncttherapy in adults (≥16 years of age) with the following seizure types when oraladministration is temporarily not feasible: Partial onset seizures. MyoclonicSeizures in Patients with Juvenile Myoclonic Epilepsy Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults with juvenile myoclonic epilepsy.
Phenytoin
Brand Names
Infatabs, Phenytoin Infatabs, Phenytek, Dilantin-125
Phenytoin
Brand Names
Infatabs, Phenytoin Infatabs, Phenytek, Dilantin-125
Form: Injection, Tablet, Suspension, Capsule
Method of administration: Oral, Intravenous, Intramuscular
FDA approval date: July 16, 1975
Classification: Anti-epileptic Agent
Phenytoin is indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures. Phenytoin is indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures. ( 1 )
Carbamazepine
Brand Names
Carbatrol, Epitol, Carbamazepin, Equetro, Tegretol
Carbamazepine
Brand Names
Carbatrol, Epitol, Carbamazepin, Equetro, Tegretol
Form: Tablet, Suspension, Capsule
Method of administration: Oral
FDA approval date: March 11, 1968
Classification: Mood Stabilizer
Epilepsy Carbamazepine is indicated for use as an anticonvulsant drug. Evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: Partial seizures with complex symptomatology (psychomotor, temporal lobe). Patients with these seizures appear to show greater improvement than those with other types. Generalized tonic-clonic seizures (grand mal). Mixed seizure patterns which include the above, or other partial or generalized seizures. Absence seizures (petit mal) do not appear to be controlled by carbamazepine. Trigeminal Neuralgia Carbamazepine is indicated in the treatment of the pain associated with true trigeminal neuralgia. Beneficial results have also been reported in glossopharyngeal neuralgia. This drug is not a simple analgesic and should not be used for the relief of trivial aches or pains.
Valproic
Generic Name
Valproic
Valproic
Generic Name
Valproic
Form: Capsule, Solution
Method of administration: Oral
FDA approval date: January 13, 1995
Classification: Anti-epileptic Agent
Valproic Acid Oral Solution is indicated for: Monotherapy and adjunctive therapy of complex partial seizures; sole and adjunctive therapy of simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures ( 1 )
Midazolam
Brand Names
Nayzilam, Seizalam
Midazolam
Brand Names
Nayzilam, Seizalam
Form: Injection, Spray, Syrup
Method of administration: Nasal, Oral, Intravenous, Intramuscular
FDA approval date: June 20, 2000
Classification: Benzodiazepine
Midazolam HCl Syrup is indicated for use in pediatric patients for sedation, anxiolysis and amnesia prior to diagnostic, therapeutic or endoscopic procedures or before induction of anesthesia. Midazolam HCl syrup is intended for use in monitored settings only and not for chronic or home use. WARNINGS MIDAZOLAM HCL SYRUP MUST BE USED AS SPECIFIED IN THE LABEL. Midazolam is associated with a high incidence of partial or complete impairment of recall for the next several hours. CLINICAL PHARMACOLOGY.
Showing 1-5 of 32
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances